Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 12 Issue: 9, November 2012

Acknowledgement

Volume:12   Issue: 9
Pp: i-iii

DOI: 10.2174/1568009611209000i
Published on: 15 November, 2012



Editorial [Hot Topic: Recent Advances in the Prevention and Therapy of Hepatocellular Carcinoma] free to download

Volume:12   Issue: 9
Pp: 1043-1044
Anupam Bishayee
DOI: 10.2174/15680096112091043
Published on: 15 November, 2012

mTOR as a Potential Target for the Prevention and Treatment of Hepatocellular Carcinoma

Volume:12   Issue: 9
Pp: 1045-1061
Laura Elisa Buitrago-Molina and Arndt Vogel
DOI: 10.2174/15680096112091045
Published on: 15 November, 2012

Targeted Therapy for Liver Cancer: Updated Review in 2012 open access plus

Volume:12   Issue: 9
Pp: 1062-1072
Masatoshi Kudo
DOI: 10.2174/15680096112091062
Published on: 15 November, 2012

Non-Coding RNAs as Therapeutic Targets in Hepatocellular Cancer

Volume:12   Issue: 9
Pp: 1073-1080
Chiara Braconi and Tushar Patel
DOI: 10.2174/15680096112091073
Published on: 15 November, 2012

Cancer Stem Cell as a Potential Therapeutic Target in Hepatocellular Carcinoma open access plus

Volume:12   Issue: 9
Pp: 1081-1094
Roberta W.C. Pang and Ronnie T.P. Poon
DOI: 10.2174/15680096112091081
Published on: 15 November, 2012

Angiogenesis in Hepatocellular Carcinoma: A Potential Target for Chemoprevention and Therapy

Volume:12   Issue: 9
Pp: 1095-1118
Anupam Bishayee and Altaf S. Darvesh
DOI: 10.2174/15680096112091095
Published on: 15 November, 2012

Role of Acyclic Retinoid in the Chemoprevention of Hepatocellular Carcinoma: Basic Aspects, Clinical Applications, and Future Prospects

Volume:12   Issue: 9
Pp: 1119-1128
Masahito Shimizu, Kenji Imai, Koji Takai and Hisataka Moriwaki
DOI: 10.2174/15680096112091119
Published on: 15 November, 2012

Prevention of Hepatocellular Carcinoma: Potential Targets, Experimental Models, and Clinical Challenges

Volume:12   Issue: 9
Pp: 1129-1159
Yujin Hoshida, Bryan C. Fuchs and Kenneth K. Tanabe
DOI: 10.2174/15680096112091129
Published on: 15 November, 2012

Role of NF-κB in Hepatocarcinogenesis and Its Potential Inhibition by Dietary Antioxidants

Volume:12   Issue: 9
Pp: 1160-1172
Howard Perry Glauert
DOI: 10.2174/15680096112091160
Published on: 15 November, 2012

Chemoprevention of Hepatocarcinogenesis with Dietary Isoprenic Derivatives: Cellular and Molecular Aspects

Volume:12   Issue: 9
Pp: 1173-1190
Thomas Prates Ong, Monica Testoni Cardozo, Aline de Conti and Fernando Salvador Moreno
DOI: 10.2174/15680096112091173
Published on: 15 November, 2012

Dietary Phytochemicals in the Chemoprevention and Treatment of Hepatocellular Carcinoma: In Vivo Evidence, Molecular Targets, and Clinical Relevance

Volume:12   Issue: 9
Pp: 1191-1232
Anupam Bishayee, Roslin J. Thoppil, Abhijeet Waghray, Jaclyn A. Kruse, Nicholas A. Novotny and Altaf S. Darvesh
DOI: 10.2174/15680096112091191
Published on: 15 November, 2012

Anti-tumor Efficacy of a Recombinant Human Arginase in Human Hepatocellular Carcinoma

Volume:12   Issue: 9
Pp: 1233-1243
Ariel K.M. Chow, Lui Ng, Hung Sing Li, Chi Wai Cheng, Colin S.C. Lam, Thomas C.C. Yau, Paul N.M. Cheng, Sheung Tat Fan, Ronnie T.P. Poon and Roberta W.C. Pang
DOI: 10.2174/15680096112091233
Published on: 15 November, 2012

Black Currant Anthocyanins Abrogate Oxidative Stress through Nrf2- Mediated Antioxidant Mechanisms in a Rat Model of Hepatocellular Carcinoma

Volume:12   Issue: 9
Pp: 1244-1257
Roslin J. Thoppil, Deepak Bhatia, Kendra F. Barnes, Erzsebet Haznagy-Radnai, Judit Hohmann, Altaf S. Darvesh and Anupam Bishayee
DOI: 10.2174/15680096112091244
Published on: 15 November, 2012